We are live on ! Find out more
HRMY icon

Harmony Biosciences

102 hedge funds and large institutions have $1.19B invested in Harmony Biosciences in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 9

50% more capital invested

Capital invested by funds: $790M → $1.19B (+$396M)

21% more funds holding

Funds holding: 84102 (+18)

5.06% more ownership

Funds ownership: 49.2%54.26% (+5.1%)

3% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 66 (0)

Holders
102
Holders Change
+18
Holders Change %
+21.43%
% of All Funds
1.79%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
27
Increased
31
Reduced
30
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Dimensional Fund Advisors
51
Dimensional Fund Advisors
Texas
$1.4M +$1.17M +36,396 New
NFC
52
Northeast Financial Consultants
Connecticut
$1.39M +$24K +746 +2%
PCM
53
Polaris Capital Management
Massachusetts
$1.18M
CIC
54
Cornercap Investment Counsel
Georgia
$1.15M -$121K -3,752 -11%
State of Wisconsin Investment Board
55
State of Wisconsin Investment Board
Wisconsin
$1.11M +$937K +29,100 New
Verition Fund Management
56
Verition Fund Management
Connecticut
$1.07M +$895K +27,799 New
California State Teachers Retirement System (CalSTRS)
57
California State Teachers Retirement System (CalSTRS)
California
$1M -$152K -4,706 -15%
TI
58
Trexquant Investment
Connecticut
$784K +$299K +9,272 +83%
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$770K +$35.3K +1,097 +6%
UBS Group
60
UBS Group
Switzerland
$695K -$306K -9,500 -34%
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$618K -$100K -3,120 -16%
Bank of America
62
Bank of America
North Carolina
$597K +$325K +10,095 +185%
Marshall Wace
63
Marshall Wace
United Kingdom
$570K +$479K +14,889 New
VEA
64
Virtus ETF Advisers
New York
$548K -$42.2K -1,312 -8%
AIG
65
American International Group
New York
$469K -$9.37K -291 -2%
Manulife (Manufacturers Life Insurance)
66
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$440K -$35.2K -1,094 -9%
DCM
67
Dupont Capital Management
Delaware
$386K +$324K +10,072 New
Vontobel Holding
68
Vontobel Holding
Switzerland
$383K
JP Morgan Chase
69
JP Morgan Chase
New York
$365K -$19.9K -617 -6%
Invesco
70
Invesco
Georgia
$362K +$61.5K +1,911 +25%
CS
71
Credit Suisse
Switzerland
$359K +$5.05K +157 +2%
MIM
72
MetLife Investment Management
New Jersey
$358K
AllianceBernstein
73
AllianceBernstein
Tennessee
$356K -$174K -5,400 -37%
VOYA Investment Management
74
VOYA Investment Management
Georgia
$340K
BFM
75
Boothbay Fund Management
New York
$327K +$275K +8,541 New

HRMY Hedge Fund Activity: Q3 2021 in Review

102 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Harmony Biosciences (HRMY) for Q3 2021, worth a combined $1.19B — up 50% from $790M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new HRMY positions and 9 closed out — a net gain of 18 holders — while 31 added to existing stakes and 30 trimmed.

The largest buyer was Vanguard Group, adding an estimated $62.4M. The largest seller was Novo Holdings A/S, cutting an estimated $44.5M.

  • 102 institutional investors held Harmony Biosciences (HRMY) as of Q3 2021, up from 84 in Q2 2021.
  • Funds reported $1.19B of Harmony Biosciences stock for Q3 2021, up 50% quarter-over-quarter.
  • 27 funds opened new Harmony Biosciences positions in Q3 2021 and 9 closed out, a net change of +18 holders.
  • The largest Harmony Biosciences buyer in Q3 2021 was Vanguard Group, an estimated $62.4M added.
  • The largest Harmony Biosciences seller in Q3 2021 was Novo Holdings A/S, an estimated $44.5M sold.

Based on aggregated 13F filings for Q3 2021.